Using whole-Pg lysates, a Pg-specific lipopolysaccharide or recombinant citrullinated Pg PAD, other investigators have previously demonstrated increased frequencies of Pg antibody responses in patients with chronic RA compared with healthy control participants [5,13-16,22], as we did using whole-sonicate antigens.